Elise Corre

P-gp activity is a critical resistance factor against AVE9633 and DM4 cytotoxicity in leukaemia cell lines, but not a major mechanism of chemoresistance in cells from acute myeloid leukaemia patients

Ruoping Tang, Simy Cohen, Jean‐Yves Perrot et al. · BMC Cancer · 2009 · 49 citations · Full text

Medicine, Oncology, Pharmacology +13

Outcome of 40 adults aged from 18 to 55 years with acute lymphoblastic leukemia treated with double-delayed intensification pediatric protocol

Stéphanie Haïat, Zora Marjanovic, Simona Lapusan et al. · Leukemia Research · 2010 · 30 citations

Medicine, Oncology, Pediatrics +10

Combination of brentuximab‐vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T‐cell lymphoma

Zoé Van de Wyngaert, Paul Coppo, Pascale Cervera et al. · European Journal Of Haematology · 2020 · 17 citations

Medicine, Hematology, Oncology +13

Efficacy and safety of daratumumab in multiresistant immune‐mediated thrombotic thrombocytopenic purpura

Júlia Weisinger, Raïda Bouzid, Dana Ranta et al. · British Journal of Haematology · 2024 · 12 citations · Full text

Life Sciences, Hematology, Immunology +17